Nanoparticles Archives - tgiHealthCareerp

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

04/06/2021 ACE2, Angiotensin, antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, Glycine, Glycoprotein, Heparin, Immune Response, immunization, Nanoparticle, Nanoparticles, protein, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Health News

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

03/15/2021 antibodies, Cell, Chemokines, coronavirus, Cytokines, fever, Immune Response, inflammation, Intracellular, Lipids, Macrophage, Nanoparticle, Nanoparticles, Necroptosis, Nucleoside, Pain, peptides, Preclinical, protein, research, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine

Lipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and

Health News

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

03/09/2021 Antigen, Cell, Chromatography, coronavirus, Coronavirus Disease COVID-19, efficacy, healthcare, Helicobacter pylori, Nanoparticle, Nanoparticles, pandemic, protein, Receptor, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine, virus, Weight Loss

COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),